Product information: An overview
Abstract
Medicinal product information serves as a vital risk minimisation resource, providing healthcare professionals with up-to-date scientific data on the benefits and risks of medicines to support informed prescribing decisions. It also empowers patients and caregivers by enhancing their understanding of prescribed treatments.
This article gives an introduction to product information, how the content is created and managed, and the benefits of transitioning from current paper patient information leaflets (PIL) to electronic product information labelling.
How to read this journal article
Thank you for visiting Regulatory Rapporteur. Journal articles are restricted to TOPRA members and registered users.
If you are a TOPRA member, or have already registered for limited free access, log in now (Option 1 below).
Not yet a member? You can either join TOPRA (Option 2 below) or register to view limited content for free (Option 3 below).
The Organisation for Professionals in Regulatory Affairs
- Contact us
- Copyright © 2015-2025 The Organisation for Professionals in Regulatory Affairs Ltd. t/a Regulatory Rapporteur - All rights reserved